Advertisement
Affymetrix, Inc.

Affymetrix, Inc. Fundamental Analysis

AFFXNASDAQ
HealthcareMedical - Healthcare Information Services
$14.01
$0.00(0.00%)
U.S. Market opens in 64h 20m
Advertisement

Affymetrix, Inc. Fundamental Analysis

Affymetrix, Inc. (AFFX) shows weak financial fundamentals with a PE ratio of 107.84, profit margin of 2.81%, and ROE of 3.31%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio0.33
Current Ratio3.78

Areas of Concern

ROE3.31%
Operating Margin4.64%
We analyze AFFX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 40.9/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
40.9/100

We analyze AFFX's fundamental strength across five key dimensions:

Efficiency Score

Weak

AFFX struggles to generate sufficient returns from assets.

ROA > 10%
1.85%

Valuation Score

Moderate

AFFX shows balanced valuation metrics.

PE < 25
107.84
PEG Ratio < 2
0.33

Growth Score

Weak

AFFX faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

AFFX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.32
Current Ratio > 1
3.78

Profitability Score

Weak

AFFX struggles to sustain strong margins.

ROE > 15%
3.31%
Net Margin ≥ 15%
2.81%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is AFFX Expensive or Cheap?

P/E Ratio

AFFX trades at 107.84 times earnings. This suggests a premium valuation.

107.84

PEG Ratio

When adjusting for growth, AFFX's PEG of 0.33 indicates potential undervaluation.

0.33

Price to Book

The market values Affymetrix, Inc. at 3.21 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.21

EV/EBITDA

Enterprise value stands at -0.51 times EBITDA. This is generally considered low.

-0.51

How Well Does AFFX Make Money?

Net Profit Margin

For every $100 in sales, Affymetrix, Inc. keeps $2.81 as profit after all expenses.

2.81%

Operating Margin

Core operations generate 4.64 in profit for every $100 in revenue, before interest and taxes.

4.64%

ROE

Management delivers $3.31 in profit for every $100 of shareholder equity.

3.31%

ROA

Affymetrix, Inc. generates $1.85 in profit for every $100 in assets, demonstrating efficient asset deployment.

1.85%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $0.34 in free cash annually.

$0.34

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

107.84

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.33

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.21

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.32

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.78

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.03

vs 25 benchmark

ROA

Return on assets percentage

0.02

vs 25 benchmark

ROCE

Return on capital employed

0.03

vs 25 benchmark

How AFFX Stacks Against Its Sector Peers

MetricAFFX ValueSector AveragePerformance
P/E Ratio107.8434.27 Worse (Expensive)
ROE3.31%377.00% Weak
Net Margin2.81%-42945.00% (disorted) Weak
Debt/Equity0.320.78 Strong (Low Leverage)
Current Ratio3.785.54 Strong Liquidity
ROA1.85%-162.00% (disorted) Weak

AFFX outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Affymetrix, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ